Video

Dr. Copeland on the Prevalence of Ovarian Cancer in the United States

Larry J. Copeland, MD, discusses the prevalence of ovarian cancer in the United States.

Larry J. Copeland, MD, professor, Obstetrics & Gynecology, College of Medicine, The Ohio State University Comprehensive Cancer Center—James, discusses the prevalence of ovarian cancer in the United States.

The prevalence trends of ovarian cancer are up, says Copeland. The prevalence trends are up, not because of the frequency of occurrence, but because patients are living longer. Additional research has the potential to exaggerate the prevalence of ovarian cancer even further.

The etiology of ovarian cancer has made it challenging to develop preventative and early detection strategies, says Copeland. Currently, tube removal is implemented as a preventative strategy.

Going forward, additional investigation is needed to understand how blood work, urine analysis, and imaging can aid in early detection of ovarian cancer, concludes Copeland.

Related Videos
Benjamin Besse, MD, PhD, director, clinical research, Gustave Roussy Institute; professor, medical oncology, Paris-Saclay University
Fred Saad, CQ, MD, FRCS, FCAHS
Eric Kumar Singhi, MD
Seth Wander, MD, PhD
Lillian L. Siu, MD, FRCPC
Marc Machaalani, MD
Mark Awad, MD, PhD, chief, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center
Rasha Cosman, BSc, MBBS, FRACP
Saad Z. Usmani, MD, MBA, FACP, FASCO
Nicholas P. McAndrew, MD, MSCE